NMR metabolomics and glycomics for cancer detection in patients with non-specific symptoms: a prospective observational cohort study
These findings validate the SCAN1 metabolomic signature in a more clinically complex cohort and indicate that integrating glycomics with metabolomics provides complementary biological information for cancer discrimination.